Invictus RG (Singapore)’s Teva Pharmaceuticals TEVA Stock Holding History

Invictus RG (Singapore)’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-7,463	Closed	-$421K	–	380
2015 Q3	$421K	Buy	7,463 +1,523	+26%	+$98.7K	0.39%	61
2015 Q2	$351K	Buy	5,940 +2,340	+65%	+$144K	0.33%	93
2015 Q1	$224K	Sell	3,600 -1,931	-35%	-$112K	0.21%	175
2014 Q4	$318K	Buy	5,531 +2,639	+91%	+$147K	0.34%	93
2014 Q3	$155K	Sell	2,892 -4,393	-60%	-$233K	0.2%	216
2014 Q2	$382K	Buy	7,285 +6,476	+800%	+$331K	0.4%	53
2014 Q1	$43K	Buy	+809	New	+$37.4K	0.05%	369
2013 Q3	–	Sell	-400	Closed	-$16K	–	678
2013 Q2	$16K	Buy	+400	New	+$15.6K	0.02%	530

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Invictus RG (Singapore)'s TEVA Position: Q4 2015 in Review

Invictus RG (Singapore) sold out of Teva Pharmaceuticals (TEVA) in Q4 2015, closing a stake of 7,463 shares — an estimated $421K sold.

Invictus RG (Singapore) first reported a position in TEVA in Q2 2013 and held it in 8 quarters. The position peaked at $421K in Q3 2015. 877 funds tracked by Wall St. Rank hold TEVA as of Q4 2015.

Invictus RG (Singapore) reported no remaining Teva Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
Invictus RG (Singapore) sold 7,463 Teva Pharmaceuticals shares in Q4 2015, an estimated $421K.
Invictus RG (Singapore) first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 8 quarters.
Invictus RG (Singapore)'s Teva Pharmaceuticals position peaked at $421K in Q3 2015.
877 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2015.

Based on Invictus RG (Singapore)'s 13F filing for Q4 2015.